The characteristic of Multi-tracers uptake in hepatocellular carcinoma of different metastatic abili

来源 :The 1st Sino-American Conference on Nuclear Medicine(首届中美核医学 | 被引量 : 0次 | 上传用户:fa2009
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: The aim of the study was to evaluate whether the multi-tracers (18F-FDG, 18F-FAC and 18F-FLT) PET imaging could differentiate and reflect the metastatic potential of hepatocellular carcinoma (HCC).Methods: Human HCC cell lines, MHCC97-H and MHCC97-L, with different metastatic potential, were cultured and implanted into nude mice.Invasion and meatastasis ability were assessed by Matrigel invasion assay in vitro and Spontaneous metastasis assay in vivo.In vivo imaging of tumor-bearing mice was obtained by animal PET/CT scan at 60min after injection of different kinds of tracers (18F-FDG, 18F-FAC and 18F-FLT) respectively.Protein expression and mRNA level of CD44 (a marker for metastasis character) was detected by Western blot and real-time PCR.The correlation between uptake of tracers and CD44 were performed by correlation analysis.Results: In vitro, MHCC97-H cells exhibited a higher level of Matrigel invasion than MHCC97-L cells.In vivo, spontaneous metastasis assay revealed that 83.3% (5/6) lymph node metastasis was found in MHCC97-H model, and 50% (3/6) in MHCC97-L.In Micro-PET study, the uptake ratio (T/NT, tumor/non-tumor) of 18F-FDG and 18F-FAC in MHCC97-H tumor-bearing models were higher than that in MHCC97-L models (18F-FDG: P<0.05, 18F-FAC: P<0.05).Whereas, the 18F-FLT uptake in MHCC97-H tumor-bearing model was significantly lower than that in MHCC97-L model (P<0.05).The expression level of CD44 in MHCC97-H tumor was higher than that in MHCC97-L.And 18F-FAC and 18F-FLT uptake was correlated with CD44 mRNA level (18F-FAC: P<0.05, 18F-FLT: P<0.05).But there was no significantly correlation between 18F-FDG uptake and CD44 mRNA level (P>0.05).Conclusions: Metastatic potential of MHCC97-H tumor was higher than MHCC97-L tumor.Combining of 18F-FDG, 18F-FAC and 18F-FLT PET imaging could predict different metastasis ability of HCC tumors.
其他文献
Objective: To establish cervical cancer Hela-NIS(+) cell lines stably expressing human sodium iodide symporter (NIS), and explore the feasibility of imaging and treatment of cervical cancer xenograft
Objective: To discuss the clinical value of hybrid SPECT/CT for the detection and estimation of the severity of ischemia caused by coronary lesions, precise localization of coronary artery plaques.Met
Objective: To investigate the function of TPS preoperative plan and TPS postoperative quality of verification in 125I seeds brachytherapy treatment of the orbital tumors.Methods: Retrospective analysi
Objective: To label the Arg-Gly-Asp containing peptide RGD which specificly bind with αvβ3 receptor expressed in tumor angiogenesis by pertechnetate, and evaluate its biodistribution in human lung ade
Objectives: To analyze the value of diagnosis in early renal damage in patients with primary nephrotic syndrome (PNS) by 99mTc-DTPA renal dynamic imaging.Methods: Twenty-one healthy controls (10 men,
Objective: Technetium 99m-N-MPO ([Tc-99m-N(mpo)(PNP5)](+)) is a cationic Tc-99m nitrido complex.The objective of this study is to evaluate its potential as a new radiotracer for myocardial perfusion i
Objective: To conclude features of combined positron emission tomography (PET) and computed tomography (CT) in detection of pelvic recurrence in patients with rectal cancer who underwent abdominoperin
Objective: Radionuclide imaging is one of the major imaging modality for molecular imaging.Optical imaging, for its high molecular specificity and sensitivity, has indispensable position in biological
Objective: 18F-fluorodeoxyglucose (FDG) PET/CT alone has limited sensitivity for the diagnosis of liver carcinoma.We hope to improve the diagnostic accuracy by combining 18F-FDG and 11C-choline PET/CT
Objective: Using qualitative and quantitative methods to analysis and explore the influence of different dosages 18F-FDG to PET model, provides the basis for clinical tracer dosage.Methods: PET/CT of